Position in ABBV
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$226,512,137
+$65,655,634 QoQ
Shares Held
1,041,483
+47.9% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
2.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Artemis Investment Management LLP holds $1,107,485,466 across 8 Drug Manufacturers - General names. ABBV ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,444,565 | $284,897,109 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,041,483 | $226,512,137 | |
| 3 | PFE |
Pfizer Inc
|
7,392,508 | $207,581,624 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,885,298 | $174,993,323 | |
| 5 | BIIB |
Biogen Inc.
|
571,571 | $104,786,111 | |
| 6 | LLY |
ELI LILLY & Co
|
92,854 | $85,404,323 | |
| 7 | JNJ |
Johnson & Johnson
|
65,168 | $15,929,665 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
52,961 | $7,381,174 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $226,512,137 | 1,041,483 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $160,856,503 | 703,998 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $181,226,589 | 782,701 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $125,960,989 | 678,596 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $118,747,555 | 566,760 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $85,976,057 | 483,827 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $13,031,310 | 65,988 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $57,165,557 | 333,288 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $82,428,111 | 452,653 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $67,828,819 | 437,690 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $57,849,440 | 388,095 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $40,615,301 | 301,457 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $82,687,530 | 518,840 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $73,901,020 | 457,280 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $50,450,612 | 375,908 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $76,621,506 | 500,271 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $77,821,391 | 480,053 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $54,081,874 | 399,423 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $40,277,363 | 373,388 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $48,632,432 | 431,751 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $67,340,003 | 622,251 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $77,897,085 | 726,991 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $40,514,842 | 462,551 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $60,158,322 | 612,735 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $70,412,664 | 924,172 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||